Immunology and immunodiagnostics

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

First, zero, pseudo-zero order elimination Clearance
All the following are antibiotics used for gram –ve bacteria.
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
1 Lecture: Forensic Serology - Immunoassays Antibody/Antigen reaction provides the means of generating a measurable result. “Immuno” refers to an immune.
THERAPEUTIC DRUG MONITORING (TDM)
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Therapeutic Drug Monitoring.
PHT 415 BASIC PHARMACOKINETICS Course Instructor:Prf. Dr. Hnaa elsaghir Assistant lecturers, Doaa elshora and eman elfakih Text: Hand book of basic pharmacokinetics,
Therapeutic Drug Monitoring (TDM)
PHL 211 Pharmacology Fifth Lecture By Abdelkader Ashour, Ph.D. Phone:
Cardiac drugs Cardiac glycoside Cardiac glycosides are the most effective drugs for treatment of C.H.F. Digitoxins are plant alkaloids. They increase myocardial.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Nonopiod (Nonnarcotic) Analgesics.
Therapeutic Drug Monitoring
Introduction to Pharmacotherapy Ghada A Bawazeer. MSc, PharmD. BCPS King Saud University-College of Pharmacy Sept
Objective: Explain the variation in dosing intervals for medications 1)Introduce Half-Life (t 1/2 ) 2)Relate Half-Life to Dosing intervals of aspirin and.
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
1 Applied Pharmacokinetics of Antiepileptic Drugs (AEDs) B. Gitanjali Gitanjali-21:
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Published Date: January 2014 No. of Pages: 249 Price: Single User: US$3500 Corporate User: US$ Strategies for the US Therapeutic Drug Monitoring.
Pharmacology Department
Calculation of Doses Prof. Dr. Henny Lucida, Apt.
Clinical Pharmacokinetics of Carbamazepine
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
BIOPHARMACEUTICS.
TDM Therapeutic Drug Monitoring
Prof. Dr. Henny Lucida, Apt
Therapeutic drug Monitoring
Chapter 22 Alcohol Lesson Two Harmful Effects of Alcohol Use Pgs
PHT 415 BASIC PHARMACOKINETICS
RELATIONSHIP OF Concentration and Response Dr. Mohd Bin Makmor Bakry, PhD, RPh Senior Lecturer in Clinical Pharmacy Intensive Care Preceptor Universiti.
Foundation Knowledge and Skills
PRESENTED BY SURUCHI SINGH M.PHARM THERAPEUTIC DRUG MONITORING 1.
Pharmacokinetic Questions
Chapter 23 Medicines & Drugs Pg Chapter 23, Lesson 1 The Role of Medicines.
Anxiolytic , Sedative and Hypnotic Drugs
THERAPEUTIC WINDOW Lecture #19. Therapeutic Effectiveness ineffective effective minor ADR major ADR Therapeutic Effectiveness = Effective Therapy –
Therapeutic Drug Monitoring (TDM) is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication concentrations.
Compartmental Models and Volume of Distribution
Approach to Acute Poisoning
FACTORS AFFECTING THERAPEUTIC DRUG MONITORING
20l of whole blood + 80 l of water +80 l of 0.1M ZnSO4
Factors Affecting Drug Activity
The aminoglycoside antibiotics
Antidysrhythmic Agents
Cyclosporine.
Mass Spectrometry Vs. Immunoassay
Fluorescence Polarization Immunoassay FPIA
Anticonvulsants: Valproic acid
Medications for Dementia
Drug Actions and Interactions
Factors affecting Drug Activity
به نام خدا. به نام خدا سم‌شناسي و مانيتورينگ دارودرماني.
Clinical Pharmacokinetics
Anxiolytic, Sedative and Hypnotic Drugs
Aminoglycosides.
Clinical Pharmacokinetics
Clinical Pharmacokinetics
THERAPEITIC DRUG MONITORING. Introduction Therapeutic drug monitoring (TDM) is a tool that can guide the clinician to provide effective and safe drug.
Clinical Pharmacokinetics
Basic Biopharmaceutics
Therapeutic Drug Monitoring chapter 1 part 1
Pharmacokinetics lecture 12 Contents ...
Therapeutic Drug Monitoring
AEROSET® & ARCHITECT® c8000® OEM Reagent Training
ARCHITECT cSystems OEM Reagent Training
Drug-drug Interactions
หัวหน้าหน่วยโรคภูมิแพ้ สถาบันสุขภาพเด็กแห่งชาติมหาราชินี
Pharmacology The science of Drugs.
AEROSET® & ARCHITECT® c8000® OEM Reagent Training
Presentation transcript:

Immunology and immunodiagnostics Lecture 8

TDM Therapeutic drug monitoring is the measurement of specific drugs at timed intervals in order to maintain a relatively constant concentration of the medication in the bloodstream. To provide information relevant to the diagnosis and management of the patients suspected to have taken overdose. To screen for the presence of drug of abuse.

Need of TDM Certain drugs have a narrow therapeutic range In concentrations above the upper limit of the range,the drug can be toxic. In concentrations below the lower limit of the range,the drug can be ineffective. Not all patients have the same response at similar doses.

Drugs should have a narrow "therapeutic index” Steady state varies from person to person and depends on Age General state of health Genetic makeup interference of other medications Various disease states

Therapeutic index a comparison of the amount of a therapeutic agent that causes the therapeutic effect to the amount that causes death (in animal studies) or toxicity (in human studies).

Therapeutic Index High therapeutic index Low therapeutic index NSAIDs Aspirin Tylenol Ibuprofen Sedative/hypnotics Benzodiazepines Most antibiotics Beta-blockers Low therapeutic index Lithium Neuroleptics Phenytoin Phenobarbital Some antibiotics Gent/Vanco/Amikacin Digoxin Immunosuppressives

DO ALL DRUGS NEED TDM? Drugs that do not need TDM: Drugs used for treating diseases with having end point BP, HR, cardiac rhythm, blood sugar, blood cholesterol and triglycerides, urine volume, body temperature, inflammation, pain, headache, etc. Drugs with less complicated pharmacokinetics. Drugs that used to treat less complicated or not life threatening diseases

COMMONLY MONITORED DRUGS 1. Bronchodilators: Theophylline 2. Antibiotics : Aminoglycosides - Gentamicin, Amikacin Others - Vancomycin 3. Immunosuppressants: Cyclosporine 4. Anticancers: Methotrexate

COMMONLY MONITORED DRUGS (cont’d) 5. Antiepileptics: Phenobarbital, Phenytoin, Carbamazepine, Valproate 6. Cardiac Drugs : Digoxin*, Procainamide, Lidocaine 7. Psychoactive Drugs: Lithium, TCA 8. Analgesics: Aspirin, Paracetamol

TDM ASSAY METHODOLOGIES 1. EMIT (Enzyme-Multiplied Immunoassay Technique) : highly automated, rapid turnaround, many assays available, homogenous, moderate sensitivity 2. ELISA: highly automated, rapid turnaround, moderate sensitivity but few assays available, heterogenous 3. RIA: high sensitivity but long turnaround,many interferences, heterogenous, radiation hazards

TDM ASSAY METHODOLOGIES (cont’d) 4. FPIA (Fluorescence Polarization Immunoassay) highly automated, rapid turnaround, many assays available, stability of reagents and calibration curves, moderate sensitivity, homogenous 5. HPLC: highest sensitivity, most assays available, least expensive but long turnaround, requires highly trained personnel

TYPES OF ASSAY REQUIRED Total drug conc. Free drug conc. Metabolites

Theophylline Bronchodilator Therapeutic range: 5 - 20 g/mL Neonates metabolize theophylline to caffeine Toxic at > 20 g/mL Nausea, vomiting, diarrhea, stomach pain, headache, insomnia, tachycardia Seizures, cardiac arrhythmia at > 35 g/mL

Gentamycin/Tobramycin Wide-spectrum aminoglycoside antibiotics Therapeutic 4 - 10 g/mL (peak); 0.5 - 1.5 g/mL (trough) Toxic: 12 - 15 g/mL Ototoxicity Nephrotoxicity

Digoxin Improves cardiac output in CHF patients Therapeutic range: 1.5 - 2.0 ng/mL Toxic levels (> 2.0 ng/mL) produce arrhythmias, GI, CNS symptoms